Cargando…

Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers

BACKGROUND: Senegal ranks 15th in the world in incidence of cervical cancer, the number one cause of cancer mortality among women in this country. The estimated participation rate for cervical cancer screening throughout Senegal is very low (6.9% of women 18–69 years old), especially in rural areas...

Descripción completa

Detalles Bibliográficos
Autores principales: Dykens, J Andrew, Linn, Annē M, Irwin, Tracy, Peters, Karen E, Pyra, Maria, Traoré, Fatoumata, Touré Diarra, Mariama, Hasnain, Memoona, Wallner, Katie, Linn, Patrick, Ndiaye, Youssoupha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291333/
https://www.ncbi.nlm.nih.gov/pubmed/28184171
http://dx.doi.org/10.2147/IJWH.S115454
_version_ 1782504761676791808
author Dykens, J Andrew
Linn, Annē M
Irwin, Tracy
Peters, Karen E
Pyra, Maria
Traoré, Fatoumata
Touré Diarra, Mariama
Hasnain, Memoona
Wallner, Katie
Linn, Patrick
Ndiaye, Youssoupha
author_facet Dykens, J Andrew
Linn, Annē M
Irwin, Tracy
Peters, Karen E
Pyra, Maria
Traoré, Fatoumata
Touré Diarra, Mariama
Hasnain, Memoona
Wallner, Katie
Linn, Patrick
Ndiaye, Youssoupha
author_sort Dykens, J Andrew
collection PubMed
description BACKGROUND: Senegal ranks 15th in the world in incidence of cervical cancer, the number one cause of cancer mortality among women in this country. The estimated participation rate for cervical cancer screening throughout Senegal is very low (6.9% of women 18–69 years old), especially in rural areas and among older age groups (only 1.9% of women above the age of 40 years). There are no reliable estimates of the prevalence of cervical dysplasia or risk factors for cervical dysplasia specific to rural Senegal. The goals of this study were to estimate the prevalence of cervical dysplasia in a rural region using visual inspection of the cervix with acetic acid (VIA) and to assess risk factors for cervical cancer control. PATIENTS AND METHODS: We conducted a cross-sectional study in which we randomly selected 38 villages across the Kédougou region using a three-stage clustering process. Between October 2013 and March 2014, we collected VIA screening results for women aged 30–50 years and cervical cancer risk factors linked to the screening result. RESULTS: We screened 509 women; 5.6% of the estimated target population (9,041) in the region. The point prevalence of cervical dysplasia (positive VIA test) was 2.10% (95% confidence interval [CI]: 0.99–3.21). Moreover, 287 women completed the cervical cancer risk factor survey (56.4% response rate) and only 38% stated awareness of cervical cancer; 75.9% of the screened women were less than 40 years of age. CONCLUSION: The overall prevalence of dysplasia in this sample was lower than anticipated. Despite both overall awareness and screening uptake being less than expected, our study highlights the need to address challenges in future prevalence estimates. Principally, we identified that the highest-risk women are the ones least likely to seek screening services, thus illustrating a need to fully understand demand-side barriers to accessing health services in this population. Targeted efforts to educate and motivate older women to seek screenings are needed to sustain an effective cervical cancer screening program.
format Online
Article
Text
id pubmed-5291333
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-52913332017-02-09 Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers Dykens, J Andrew Linn, Annē M Irwin, Tracy Peters, Karen E Pyra, Maria Traoré, Fatoumata Touré Diarra, Mariama Hasnain, Memoona Wallner, Katie Linn, Patrick Ndiaye, Youssoupha Int J Womens Health Original Research BACKGROUND: Senegal ranks 15th in the world in incidence of cervical cancer, the number one cause of cancer mortality among women in this country. The estimated participation rate for cervical cancer screening throughout Senegal is very low (6.9% of women 18–69 years old), especially in rural areas and among older age groups (only 1.9% of women above the age of 40 years). There are no reliable estimates of the prevalence of cervical dysplasia or risk factors for cervical dysplasia specific to rural Senegal. The goals of this study were to estimate the prevalence of cervical dysplasia in a rural region using visual inspection of the cervix with acetic acid (VIA) and to assess risk factors for cervical cancer control. PATIENTS AND METHODS: We conducted a cross-sectional study in which we randomly selected 38 villages across the Kédougou region using a three-stage clustering process. Between October 2013 and March 2014, we collected VIA screening results for women aged 30–50 years and cervical cancer risk factors linked to the screening result. RESULTS: We screened 509 women; 5.6% of the estimated target population (9,041) in the region. The point prevalence of cervical dysplasia (positive VIA test) was 2.10% (95% confidence interval [CI]: 0.99–3.21). Moreover, 287 women completed the cervical cancer risk factor survey (56.4% response rate) and only 38% stated awareness of cervical cancer; 75.9% of the screened women were less than 40 years of age. CONCLUSION: The overall prevalence of dysplasia in this sample was lower than anticipated. Despite both overall awareness and screening uptake being less than expected, our study highlights the need to address challenges in future prevalence estimates. Principally, we identified that the highest-risk women are the ones least likely to seek screening services, thus illustrating a need to fully understand demand-side barriers to accessing health services in this population. Targeted efforts to educate and motivate older women to seek screenings are needed to sustain an effective cervical cancer screening program. Dove Medical Press 2017-01-27 /pmc/articles/PMC5291333/ /pubmed/28184171 http://dx.doi.org/10.2147/IJWH.S115454 Text en © 2017 Dykens et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Dykens, J Andrew
Linn, Annē M
Irwin, Tracy
Peters, Karen E
Pyra, Maria
Traoré, Fatoumata
Touré Diarra, Mariama
Hasnain, Memoona
Wallner, Katie
Linn, Patrick
Ndiaye, Youssoupha
Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
title Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
title_full Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
title_fullStr Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
title_full_unstemmed Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
title_short Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
title_sort implementing visual cervical cancer screening in senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291333/
https://www.ncbi.nlm.nih.gov/pubmed/28184171
http://dx.doi.org/10.2147/IJWH.S115454
work_keys_str_mv AT dykensjandrew implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT linnannem implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT irwintracy implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT peterskarene implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT pyramaria implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT traorefatoumata implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT tourediarramariama implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT hasnainmemoona implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT wallnerkatie implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT linnpatrick implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers
AT ndiayeyoussoupha implementingvisualcervicalcancerscreeninginsenegalacrosssectionalstudyofriskfactorsandprevalencehighlightingserviceutilizationbarriers